Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass

Thrombosis Research

Volumn 122, Issue 2, 2008, Pages 161-166

  Wang, Yuliang ^a,b   Liu, Yawu ^c   Han, Ruifa ^a   Zhu, Zhijun ^b   Zhang, Yanyan ^a,d   Wang, Xueqian ^e   Wang, Liang ^b   Shen, Zhongyang ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e TIANJIN HOSPITAL   (China)

Author keywords

Hemostasis; Ischemia reperfusion; Liver transplantation

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; D DIMER; DACLIZUMAB; FIBRINOGEN; HEMOGLOBIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLASMINOGEN; PROTEIN C; TACROLIMUS; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BILIARY CIRRHOSIS; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LIVER TRANSPLANTATION; MALE; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; RADIAL ARTERY; THROMBIN TIME; THROMBOCYTE COUNT; VEIN BYPASS;

ADULT; ANTIPLASMIN; ANTITHROMBIN III; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; LIPOPROTEINS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PLASMINOGEN; PROTEIN C; VON WILLEBRAND FACTOR;

EID: 44449107069     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.10.002     Document Type: Article

References (21)

1. Porte R.J. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights. Semin Thromb Hemost 19 (1993) 191-196
2. Peck-Radosavljevic M., Wichlas M., Zacherl J., Stiegler G., Stohlawetz P., Fuchsjäger M., Kreil A., Metz-Schimmerl S., Panzer S., Steininger R., Mühlbacher F., Ferenci P., Pidlich J., and Gangl A. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood 95 (2000) 795-801
3. Yadav S.S., Howell D.N., Steeber D.A., Harland R.C., Tedder T.F., and Clavien P.A. P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 29 (1999) 1494-1502
4. Lip G.Y., and Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?. Cardiovasc Res 34 (1997) 255-265
5. Nichols W.C., and Ginsburg D. von Willebrand disease. Medicine 76 (1997) 1-20
6. McNicol P.L., Liu G., Harley I.D., McCall P.R., Przybylowski G.M., Bowkett J., Angus P.W., Hardy K.J., and Jones R.M. Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thrombelastography. Anaesth Intensive Care 22 (1994) 659-665
7. Kang Y. Coagulation and liver transplantation: current concepts. Liver Transpl Surg 3 (1997) 465-467
8. Harding S.A., Mallett S.V., Peachey T.D., and Cox D.J. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth 78 (1997) 175-179
9. Sato M., Nashan B., Ringe B., Grosse H., Barthels M., and Pichlmayr R. Coagulation disorder during liver transplantation. Blood Coagul Fibrinolysis 2 (1991) 25-31
10. Eng H.L., Chen Y.S., Jawan B., Cheng Y.F., Chiang Y.C., Chen W.J., Huang T.L., Cheung H.K., Wang C.C., Lin C.L., Huang C.B., Huang C.C., and Chen C.L. Soluble thrombomodulin antigen as a marker for endothelial damage during liver transplantation. Transplant Proc 32 (2000) 2273-2275
11. Wang Y.I., Li G., Zhang Y., Gao W., and Yao Z. The expression of von Willebrand factor, soluble thrombomodulin and soluble P-selectin during orthotopic liver transplantation. Transplant Proc 39 (2007) 172-175
12. Ilmakunnas M., Petäjä J., Höckerstedt K., Mäkisalo H., Fernandez J.A., Griffin J.H., Jansson S.E., Repo H., and Pesonen E.J. Activation of protein C during reperfusion in clinical liver transplantation. Transplantation 75 (2003) 467-472
13. Bajaj M.S., Birktoft J.J., Steer S.A., and Bajaj S.P. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 86 (2001) 959-972
14. Ariëns R.A., Alberio G., Moia M., and Mannucci P.M. Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis. Thromb Haemost 81 (1999) 203-207
15. Arai M., Mochida S., Ohno A., and Fujiwara K. Blood coagulation in the hepatic sinusoids as a contributing factor in liver injury following orthotopic liver transplantation in the rat. Transplantation 62 (1996) 1398-1401
16. Yoshimura N., Kobayashi Y., Nakamura K., Yamagishi H., and Oka T. The effect of tissue factor pathway inhibitor on hepatic ischemic reperfusion injury of the rat. Transplantation 67 (1999) 45-53
17. Segal H.C., Hunt B.J., Cottam S., Downing A., Beard C., Francis J.L., Potter D., and Tan K.C. Fibrinolytic activity during orthotopic liver transplantation with and without aprotinin. Transplantation 58 (1994) 1356-1360
18. Ozier Y., Steib A., Ickx B., Nathan N., Derlon A., Guay J., and De Moerloose P. Haemostatic disorders during liver transplantation. Eur J Anaesthesiol 18 (2001) 208-218
19. Legnani C., Palareti G., Rodorigo G., Gozzetti G., Mazziotti A., Martinelli G., Zanello M., Sama C., and Coccheri S. Protease activities, as well as plasminogen activators, contribute to the "lytic" state during orthotopic liver transplantation. Transplantation 56 (1993) 568-572
20. Cheema S.P., Webster N.R., Dunn F., and Bellamy M.C. Mediators of fibrinolysis in orthotopic liver transplantation. Clin Transplant 10 (1996) 24-27
21. Crookston K.P., Marsh C.L., and Chandler W.L. A kinetic model of the circulatory regulation of tissue plasminogen activator during orthotopic liver transplantation. Blood Coagul Fibrinolysis 11 (2000) 79-88